108 related articles for article (PubMed ID: 17574964)
1. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
Vuoristo MS
Cancer Genet Cytogenet; 2007 Jul; 176(1):54-7. PubMed ID: 17574964
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma.
Kleinrath T; Gassner C; Lackner P; Thurnher M; Ramoner R
J Clin Oncol; 2007 Mar; 25(7):845-51. PubMed ID: 17327605
[TBL] [Abstract][Full Text] [Related]
3. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
[TBL] [Abstract][Full Text] [Related]
5. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
Beretta L; Cappiello F; Barili M; Scorza R
Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
[TBL] [Abstract][Full Text] [Related]
7. IL-10 promoter polymorphisms influence disease severity and course in psoriasis.
Kingo K; Kõks S; Silm H; Vasar E
Genes Immun; 2003 Sep; 4(6):455-7. PubMed ID: 12944983
[TBL] [Abstract][Full Text] [Related]
8. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.
Seo KW; Kim DH; Sohn SK; Lee NY; Chang HH; Kim SW; Jeon SB; Baek JH; Kim JG; Suh JS; Lee KB
Bone Marrow Transplant; 2005 Dec; 36(12):1089-95. PubMed ID: 16247433
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
Eder T; Mayer R; Langsenlehner U; Renner W; Krippl P; Wascher TC; Pummer K; Kapp KS
Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
[TBL] [Abstract][Full Text] [Related]
10. The interleukin-10 promoter haplotype ATA is a putative risk factor for aggressive periodontitis.
Reichert S; Machulla HK; Klapproth J; Zimmermann U; Reichert Y; Gläser CH; Schaller HG; Stein J; Schulz S
J Periodontal Res; 2008 Feb; 43(1):40-7. PubMed ID: 18230105
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism.
Helminen ME; Kilpinen S; Virta M; Hurme M
J Infect Dis; 2001 Sep; 184(6):777-80. PubMed ID: 11517440
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis.
Takakura M; Tokushige K; Matsushita N; Hashimoto E; Shiratori K
J Gastroenterol Hepatol; 2007 Aug; 22(8):1271-7. PubMed ID: 17559370
[TBL] [Abstract][Full Text] [Related]
13. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain.
Rueda B; Roibas B; Martin J; Gonzalez-Gay MA
J Rheumatol; 2007 Jul; 34(7):1535-9. PubMed ID: 17552041
[TBL] [Abstract][Full Text] [Related]
14. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
[TBL] [Abstract][Full Text] [Related]
18. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
19. Haplotype-tagging interleukin-10 promoter polymorphism is associated with reduced risk of retinal artery occlusion.
Weger M; Steinbrugger I; El-Shabrawi Y; Wegscheider BJ; Weger W; Renner W; Schmut O; Haas A
Mol Vis; 2007 Apr; 13():549-52. PubMed ID: 17438520
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
